[Other] Pembrolizumab in patients with rare and ultra-rare sarcomas (AcS谷 Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial

eraswr Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-08 19:37
Reward10points

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    950


Return to the list